N-acetyl-p-benzoquinonimine metabolite as a factor of possible neurotoxicity of paracetamol

Abstract

BACKGROUND: Currently, the possible negative effects of paracetamol on the central nervous system are widely discussed in the modern scientific literature. The relationship between the intake of paracetamol during pregnancy by women and the risk of autism spectrum disorders in their children is being studied. However, such conclusions are often met with serious criticism as there are many questions about the methods of assessing behavioral disorders and processing research results. Therefore, experimental data obtained on neuronal cells may be a sufficient ground to confirm or refute assumptions about the neurotoxicity of paracetamol and its metabolites.

AIM: To study the effect of paracetamol and its metabolite N-acetyl-p-benzoquinonimine (NAPQI) on the neurons of the cerebral cortex of fetal rats.

MATERIALS AND METHODS: The study of the effect of paracetamol and its metabolite NAPQI on cell viability has been carried out by a method based on the reduction of 3-(4,5-dimethylthiazole-2-yl)-2,5-tetrazolium bromide (MTT).

RESULTS: It has been shown that during preincubation of neurons in the cerebral cortex of the rats with paracetamol at a concentration of 1 mg/ml for 24 hours and subsequent incubation with 0.3 mM hydrogen peroxide, both hydrogen peroxide and paracetamol itself reduce the viability of neurons. Joint incubation with paracetamol and hydrogen peroxide also reduces the viability of neurons. The same effect of paracetamol and its metabolite is observed with the joint preincubation of paracetamol or NAPQI and hydrogen peroxide.

CONCLUSIONS: Paracetamol as well its metabolite NAPQI reduce the viability of neurons in the fetal cortex of rats.

Keywords

neurons / PC12 line / paracetamol / NAPQI

References

[1] Bandoli G, Palmsten K, Chambers C. Acetaminophen use in pregnancy: Examining prevalence, timing, and indication of use in a prospective birth cohort. Paediatr Perinat Epidemiol. 2020;34(3):237–246. DOI: 10.1111/ppe.12595

[2] Bandoli G., Palmsten K., Chambers C. Acetaminophen use in pregnancy: Examining prevalence, timing, and indication of use in a prospective birth cohort // Paediatr. Perinat. Epidemiol. 2020. Vol. 34, No. 3. P. 237–246. DOI: 10.1111/ppe.12595

[3] Chiew AL, Buckley NA. Acetaminophen Poisoning. Crit Care Clin. 2021;37(3):543–561. DOI: 10.1016/j.ccc.2021.03.005

[4] Chiew A.L., Buckley N.A. Acetaminophen Poisoning // Crit. Care Clin. 2021. Vol. 37, No. 3. P. 543–561. DOI: 10.1016/j.ccc.2021.03.005

[5] Ni HM, McGill MR, Chao X, et al. Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice. J Hepatol. 2016;65(2):354–362. DOI: 10.1016/j.jhep.2016.04.025

[6] Ni H.M., McGill M.R., Chao X. et al. Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice // J. Hepatol. 2016. Vol. 65, No. 2. P. 354–362. DOI: 10.1016/j.jhep.2016.04.025

[7] Ramachandran A, Jaeschke H. Acetaminophen toxicity: Novel insights into mechanisms and future perspectives. Gene Expr. 2018;18(1):19–30. DOI: 10.3727/105221617X15084371374138

[8] Ramachandran A., Jaeschke H. Acetaminophen toxicity: Novel insights into mechanisms and future perspectives // Gene Expr. 2018. Vol. 18, No. 1. P. 19–30. DOI: 10.3727/105221617X15084371374138

[9] Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol. 2011;8(4):202–211. DOI: 10.1038/nrgastro.2011.22

[10] Tujios S., Fontana R.J. Mechanisms of drug-induced liver injury: from bedside to bench // Nat. Rev. Gastroenterol. Hepatol. 2011. Vol. 8, No. 4. P. 202–211. DOI: 10.1038/nrgastro.2011.22

[11] Eke AC. An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics. J Basic Clin Physiol Pharmacol. 2021. DOI: 10.1515/jbcpp-2021-0312

[12] Eke A.C. An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics // J. Basic Clin. Physiol. Pharmacol. 2021. DOI: 10.1515/jbcpp-2021-0312

[13] Stergiakouli E, Thapar A, Davey Smith G. Association of acetaminophen use during pregnancy with behavioral problems in childhood: evidence against confounding. JAMA Pediatr. 2016;170(10):964–970. DOI: 10.1001/jamapediatrics.2016.1775

[14] Stergiakouli E., Thapar A., Davey Smith G. Association of acetaminophen use during pregnancy with behavioral problems in childhood: evidence against confounding // JAMA Pediatr. 2016. Vol. 170, No. 10. P. 964–970. DOI: 10.1001/jamapediatrics.2016.1775

[15] Avrova NF, Sokolova TV, Vlasova YA, et al. Protective and antioxidative effects of GM1 ganglioside in PC12 cells exposed to hydrogen peroxide are mediated by trk tyrosine kinase. Neurochem Res. 2010;35(1):85–98. DOI: 10.1007/s11064-009-0033-6

[16] Avrova N.F., Sokolova T.V., Vlasova Y.A. et al. Protective and antioxidative effects of GM1 ganglioside in PC12 cells exposed to hydrogen peroxide are mediated by trk tyrosine kinase // Neurochem. Res. 2010. Vol. 35, No. 1. P. 85–98. DOI: 10.1007/s11064-009-0033-6

[17] Vlasova YuA, Golovanova NE, Beishebaeva ChR, et al. Study of neurotoxicity of paracetamol and its metabolite NAPQI (short message). Laboratory Animals for Science. 2021;4. DOI: 10.29296/2618723X-2021-04-09

[18] Власова Ю.А., Голованова Н.Э., Бейшебаева Ч.Р. и др. Исследование нейротоксичности парацетамола и его метаболита NAPQI (краткое сообщение) // Лабораторные животные для научных исследований. 2021. Т. 4. DOI: 10.29296/2618723X-2021-04-09

[19] Liew Z, Ritz B, Virk J, Olsen J. Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study. Autism Res. 2016;9(9):951–958. DOI: 10.1002/aur.1591

[20] Liew Z., Ritz B., Virk J., Olsen J. Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study // Autism. Res. 2016. Vol. 9, No. 9. P. 951–958. DOI: 10.1002/aur.1591

[21] Ystrom E, Gustavson K, Brandlistuen RE, et al. Prenatal Exposure to Acetaminophen and Risk of ADHD. Pediatrics. 2017;140(5):e20163840. DOI: 10.1542/peds.2016-3840

[22] Ystrom E., Gustavson K., Brandlistuen R.E. et al. Prenatal Exposure to Acetaminophen and Risk of ADHD // Pediatrics. 2017. Vol. 140, No. 5. P. e20163840. DOI: 10.1542/peds.2016-3840

[23] Liew Z, Kioumourtzoglou MA, Roberts AL, et al. Use of negative control exposure analysis to evaluate confounding: an example of acetaminophen exposure and attention-deficit/hyperactivity disorder in Nurses’ Health Study II. Am J Epidemiol. 2019;188(4):768–775. DOI: 10.1093/aje/kwy288

[24] Liew Z., Kioumourtzoglou M.A., Roberts A.L. et al. Use of negative control exposure analysis to evaluate confounding: an example of acetaminophen exposure and attention-deficit/hyperactivity disorder in Nurses’ Health Study II // Am. J. Epidemiol. 2019. Vol. 188, No. 4. P. 768–775. DOI: 10.1093/aje/kwy288

[25] Gou X, Wang Y, Tang Y, et al. Association of maternal prenatal acetaminophen use with the risk of attention deficit/hyperactivity disorder in offspring: A meta-analysis. Aust NZ J Psychiatry. 2019;53(3):195–206. DOI: 10.1177/0004867418823276

[26] Gou X., Wang Y., Tang Y. et al. Association of maternal prenatal acetaminophen use with the risk of attention deficit/hyperactivity disorder in offspring: A meta-analysis // Aust. N.Z. J. Psychiatry. 2019. Vol. 53, No. 3. P. 195–206. DOI: 10.1177/0004867418823276

[27] Bührer C, Endesfelder S, Scheuer T, Schmitz T. Paracetamol (Acetaminophen) and the developing brain. Int J Mol Sci. 2021;22(20):11156. DOI: 10.3390/ijms222011156

[28] Bührer C., Endesfelder S., Scheuer T., Schmitz T. Paracetamol (Acetaminophen) and the Developing Brain // Int. J. Mol. Sci. 2021. Vol. 22, No. 20. P. 11156. DOI: 10.3390/ijms222011156

[29] Rigobello C, Klein RM, Debiasi JD, et al. Perinatal exposure to paracetamol: Dose and sex-dependent effects in behaviour and brain’s oxidative stress markers in progeny. Behav Brain Res. 2021;408:113294. DOI: 10.1016/j.bbr.2021.113294

[30] Rigobello C., Klein R.M., Debiasi J.D. et al. Perinatal exposure to paracetamol: Dose and sex-dependent effects in behaviour and brain’s oxidative stress markers in progeny // Behav. Brain Res. 2021. Vol. 408. P. 113294. DOI: 10.1016/j.bbr.2021.113294

[31] Aleksandrova AV, Senyavina NV, Maltseva DV, et al. p53- and Caspase-3-independent mechanism of acetaminophen effect on human neural cells. Bull Exp Biol Med. 2016;160(6):763–766. DOI: 10.1007/s10517-016-3304-7

[32] Aleksandrova A.V., Senyavina N.V., Maltseva D.V. et al. p53- and Caspase-3-independent mechanism of acetaminophen effect on human neural cells // Bull. Exp. Biol. Med. 2016. Vol. 160, No. 6. P. 763–766. DOI: 10.1007/s10517-016-3304-7

[33] Vlasova YuA, Zagorodnikova KA, Ivanova IS, Chukhno AS. The impact of oxidative stress on the neurotoxic effect of acetaminophen. Butlerov Communications. 2019;59(9):106–109. (In Russ.)

[34] Власова Ю.А., Загородникова К.А., Иванова И.С., Чухно А.С. Влияние окислительного стресса на нейротоксический эффект ацетаминофена // Бутлеровские сообщения. 2019. Т. 59, № 9. С. 106–109.

[35] Vlasova YuA, Zagorodnikova KA, Gajkovaya LB. Acetaminofen (paracetamol) v vysokikh koncentraciyakh snizhaet zhiznesposobnost’ kletok RS12. Proceedings of the Vserossijskaya nauchno-prakticheskaya konferenciya s mezhdunarodnym uchastiem “Profilakticheskaya medicina – 2019”; Sankt-Peterburg, Nov 14–15, 2019. Saint Petersburg; 2019. P. 110–115. (In Russ.)

[36] Власова Ю.А., Загородникова К.А., Гайковая Л.Б. Ацетаминофен (парацетамол) в высоких концентрациях снижает жизнеспособность клеток РС12 // Профилактическая медицина – 2019: сборник научных трудов Всероссийской научно-практической конференции с международным участием, Санкт-Петербург, 14–15 ноября 2019 года. СПб., 2019. С. 110–115.

[37] Schultz S, DeSilva M, Gu T, et al. Effects of the analgesic acetaminophen (paracetamol) and its para-aminophenol metabolite on viability of mouse-cultured cortical neurons. Basic Clin Pharmacol Toxicol. 2012;110(2):141–144. DOI: 10.1111/j.1742-7843.2011.00767.x

[38] Schultz S., DeSilva M., Gu T. et al. Effects of the analgesic acetaminophen (paracetamol) and its para-aminophenol metabolite on viability of mouse-cultured cortical neurons // Basic Clin. Pharmacol.Toxicol. 2012. Vol. 110, No. 2. P. 141–144. DOI: 10.1111/j.1742-7843.2011.00767.x

RIGHTS & PERMISSIONS

Vlasova Y.A., Zagorodnikova K.A.